Licensing partner required a plant-derived technology

Our industry partner, Watercress Research Ltd are looking for a licensing partner for their plant-derived technology with a proven anti-inflammatory effect. There is a potential range of applications from personal care (skincare, oral care, baby care, fem health), OTC and pharma healthcare (nasal sprays, xerosis, gut health) and hand hygiene, wound prevention (IAD) to food packaging, food and agricultural waste, sustainable economy/recycling. Its effects could also impact on the microbiome in these contexts.

They have developed a sterile, stable plant extract and extraction procedure that concentrates phenyl ethyl isothiocyanate (PEITC) as well as the naturally occurring urease inhibitors and have a patent pending on the extraction process. PEITC is currently being researched for its role in regulating inflammation and beneficial epigenetic modifications against various forms of cancer. Urease inhibitors act on the bacterial urease enzyme which converts urea to ammonia and is implicated in a range of pathological conditions including nappy rash, Helicobacter Pylori survival, amongst others. As a by-product they have created a protein/fibre extract rich in amino acids that they are also looking to commercialise.